U.S. 3 Year Treasury Note-0.002 3.855% U.S. 5 Year Treasury Note-0.005 3.968% U.S. 7 Year Treasury Note-0.016 4.144% ...
aTyr Pharma, Inc. engages in the discovery and development of medicines based on novel biological pathways. Its product pipeline includes ATYR1923, ATYR2810, NRP2 mAbs, and AARS-1, DARS-1. The company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results